Trials / Unknown
UnknownNCT03826277
Efficacy of Melanostop Peeling for Improvement of Melasma
The Efficacy of Melanostop Peel in Combination With Specifically Selected Home Care Regimen for Improvement of Melasma
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- VIST - Faculty of Applied Sciences · Academic / Other
- Sex
- Female
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
Participants with face melasma will receive 4 Melanostop peel treatments containing 20% azelaic acid, 10% resorcinol and 6% phytic acid. Peels will be performed at 2-week interval. They will also receive a facial tonic and cream for at home use, containing brightening ingredients: vitamin C, niacinamide, alpha arbutin, kojic acid. They will also receive sunscreen protection cream with SPF 50, protecting against UVA, UVB, HEV and IR. Products for at home use will be used twice a day, every day. Measurements will be made at baseline, on the day of the forth peel treatment and 4 weeks after the last peel. Measured parameters will be: mMASI score, VisioFace photography analysis, melasma area measurements, and melanin index, ΔE, CIELab colour measurements with Cortex SkinLab Combo (Cortex Technology Asp, Denmark).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Melanostop peel | Melanostop peel treatments containing 20% azelaic acid, 10% resorcinol, 6% phytic acid, 3% tranexamic acid. (4 treatments, performed at 2-week intervals), in combination with home care products (twice daily): * a facial tonic and cream containing brightening ingredients: vitamin C, niacinamide, alpha arbutin, kojic acid, * sunscreen protection cream with SPF 50, protecting against UVA, UVB, HEV and IR |
Timeline
- Start date
- 2019-02-01
- Primary completion
- 2024-08-01
- Completion
- 2024-12-01
- First posted
- 2019-02-01
- Last updated
- 2023-04-26
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT03826277. Inclusion in this directory is not an endorsement.